Loading...
Header Logo
Keywords
Last Name
Institution

Anne Marie Comeau

Concepts (241)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neonatal Screening
33
2016
78
7.000
Why?
Cystic Fibrosis
15
2010
95
3.090
Why?
Infant, Newborn
43
2016
733
1.840
Why?
Severe Combined Immunodeficiency
7
2014
39
1.730
Why?
Receptors, Antigen, T-Cell
4
2014
229
0.990
Why?
Genetic Testing
6
2010
76
0.920
Why?
Genetic Diseases, Inborn
3
2015
32
0.920
Why?
Algorithms
8
2010
639
0.890
Why?
Polymerase Chain Reaction
11
2012
455
0.860
Why?
DNA Mutational Analysis
6
2010
149
0.800
Why?
Trypsinogen
5
2010
6
0.790
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
5
2010
72
0.590
Why?
Program Development
3
2010
163
0.520
Why?
Program Evaluation
5
2016
317
0.500
Why?
Massachusetts
10
2010
1473
0.500
Why?
Health Plan Implementation
2
2010
29
0.500
Why?
Humans
49
2016
34410
0.490
Why?
Parents
3
2014
179
0.490
Why?
Genetic Counseling
3
2005
12
0.480
Why?
HIV Infections
9
2008
673
0.480
Why?
Pilot Projects
6
2014
510
0.480
Why?
Hematologic Tests
1
2010
11
0.480
Why?
Immunoassay
3
2010
44
0.470
Why?
DNA, Viral
4
2008
200
0.470
Why?
Immunologic Deficiency Syndromes
3
2015
75
0.410
Why?
Quality Assurance, Health Care
1
2010
223
0.400
Why?
Sweat
4
2010
4
0.380
Why?
Evidence-Based Medicine
4
2016
301
0.360
Why?
T-Lymphocytes
5
2015
901
0.350
Why?
Infant
12
2016
961
0.340
Why?
DNA
3
2010
613
0.340
Why?
Diffusion of Innovation
1
2006
48
0.330
Why?
Mutation
7
2015
1747
0.320
Why?
Professional Competence
1
2006
73
0.320
Why?
HIV Seropositivity
3
1997
75
0.320
Why?
Blood Specimen Collection
5
2010
20
0.320
Why?
Needs Assessment
1
2005
110
0.310
Why?
Advisory Committees
2
2016
30
0.310
Why?
HIV
2
1996
57
0.300
Why?
HIV-1
7
2008
580
0.300
Why?
Chlorides
4
2010
36
0.300
Why?
Predictive Value of Tests
5
2010
700
0.290
Why?
Child Health Services
1
2004
46
0.280
Why?
Communication
1
2005
275
0.270
Why?
Patient Acceptance of Health Care
1
2005
259
0.270
Why?
Primary Health Care
3
2015
410
0.270
Why?
False Positive Reactions
4
2010
61
0.260
Why?
Sensitivity and Specificity
7
2008
786
0.240
Why?
Decision Making
3
2016
216
0.240
Why?
Genes, T-Cell Receptor
2
2010
8
0.230
Why?
United States
12
2014
4071
0.230
Why?
Feasibility Studies
3
2010
260
0.210
Why?
Quality Indicators, Health Care
2
2010
248
0.190
Why?
Lymphopenia
2
2014
41
0.190
Why?
Sequence Analysis, DNA
2
2008
308
0.190
Why?
New England
2
2010
198
0.190
Why?
Practice Guidelines as Topic
3
2012
449
0.190
Why?
HIV Antibodies
3
1996
117
0.180
Why?
Mass Screening
3
2016
324
0.180
Why?
Infectious Disease Transmission, Vertical
5
2008
49
0.180
Why?
Aftercare
2
2005
17
0.170
Why?
Follow-Up Studies
3
2010
1549
0.160
Why?
Genotype
4
2008
481
0.160
Why?
Models, Organizational
2
2005
78
0.160
Why?
Guanine Nucleotide Exchange Factors
1
2015
45
0.160
Why?
Disease Management
1
2015
116
0.160
Why?
AIDS Serodiagnosis
2
1997
24
0.150
Why?
Third-Party Consent
1
2014
4
0.150
Why?
Retrospective Studies
3
2014
2578
0.150
Why?
United States Dept. of Health and Human Services
1
2013
5
0.150
Why?
Calibration
2
2010
48
0.140
Why?
Intestinal Atresia
1
2013
2
0.140
Why?
Lipids
1
2015
230
0.140
Why?
Outcome Assessment (Health Care)
2
2007
404
0.140
Why?
DNA, Circular
1
2012
5
0.140
Why?
False Negative Reactions
3
2005
32
0.140
Why?
Leukopenia
1
2012
13
0.140
Why?
Intestines
1
2013
132
0.130
Why?
Biomedical Research
1
2014
141
0.130
Why?
Point-of-Care Systems
1
2012
66
0.130
Why?
alpha-Thalassemia
1
2010
3
0.120
Why?
Child
4
2013
2691
0.120
Why?
Incidence
3
2014
833
0.120
Why?
Public Health Practice
1
2010
15
0.120
Why?
Leukodystrophy, Globoid Cell
1
2010
3
0.120
Why?
Health Knowledge, Attitudes, Practice
2
2005
575
0.120
Why?
Female
11
2016
19055
0.120
Why?
Ribonucleases
1
2010
27
0.120
Why?
Quality Control
1
2010
48
0.120
Why?
Gene Dosage
1
2010
44
0.120
Why?
Child, Preschool
5
2015
1328
0.110
Why?
Rare Diseases
1
2010
16
0.110
Why?
Cardiovascular Diseases
1
2015
566
0.110
Why?
Expert Testimony
1
2010
29
0.110
Why?
Reproducibility of Results
2
2010
993
0.110
Why?
Carrier State
1
2009
13
0.110
Why?
Oropharynx
1
2009
9
0.110
Why?
Regression Analysis
1
2010
431
0.110
Why?
Pregnancy Complications, Infectious
2
2000
49
0.100
Why?
Decision Trees
2
2005
35
0.100
Why?
Developing Countries
1
2008
47
0.100
Why?
Acyl-CoA Dehydrogenase
1
2008
7
0.100
Why?
Male
8
2015
17402
0.100
Why?
Decision Making, Organizational
2
2005
25
0.100
Why?
Intensive Care Units
1
2010
207
0.100
Why?
Proteins
1
2013
574
0.100
Why?
Time Factors
4
2005
2618
0.100
Why?
Heterozygote Detection
2
2004
16
0.090
Why?
Referral and Consultation
3
2005
226
0.090
Why?
Aging
1
1992
523
0.090
Why?
Pseudomonas Infections
1
2006
25
0.090
Why?
Delivery of Health Care
1
2008
166
0.090
Why?
Reference Standards
1
2006
43
0.090
Why?
Iontophoresis
1
2005
2
0.080
Why?
Parental Consent
1
2005
6
0.080
Why?
Physician Executives
1
2005
20
0.080
Why?
Lung Diseases
1
2006
109
0.080
Why?
Models, Psychological
1
2005
92
0.080
Why?
Clinical Protocols
1
2005
88
0.080
Why?
RNA, Viral
2
2003
200
0.070
Why?
Forecasting
1
2004
159
0.070
Why?
Virology
1
2003
11
0.070
Why?
Nucleic Acid Amplification Techniques
1
2003
18
0.070
Why?
Attitude to Health
1
2005
253
0.070
Why?
Costs and Cost Analysis
1
2003
80
0.070
Why?
Social Support
1
2005
244
0.070
Why?
Metabolism, Inborn Errors
1
2002
15
0.060
Why?
Attitude of Health Personnel
1
2005
384
0.060
Why?
Carboxylic Acids
1
2001
10
0.060
Why?
Amino Acid Metabolism, Inborn Errors
1
2001
11
0.060
Why?
Lipid Metabolism, Inborn Errors
1
2001
11
0.060
Why?
Informed Consent
1
2002
101
0.060
Why?
Zidovudine
1
2000
15
0.060
Why?
Fatty Acids
1
2001
139
0.060
Why?
B-Lymphocytes
2
2015
543
0.060
Why?
Health Policy
1
2002
130
0.060
Why?
Cohort Studies
1
2004
1441
0.060
Why?
Anti-HIV Agents
1
2000
120
0.050
Why?
Cellulose
1
1999
19
0.050
Why?
HIV Seroprevalence
1
1997
9
0.050
Why?
Risk Factors
3
2015
3077
0.050
Why?
Risk
2
2010
349
0.050
Why?
Globins
1
1996
27
0.050
Why?
Point Mutation
2
2008
148
0.050
Why?
Reference Values
2
2009
308
0.040
Why?
Blood Stains
1
1996
1
0.040
Why?
Blood Preservation
1
1996
8
0.040
Why?
National Health Programs
1
2016
11
0.040
Why?
Immunoglobulin A
1
1996
41
0.040
Why?
rac1 GTP-Binding Protein
1
2015
12
0.040
Why?
Genes, Recessive
1
2015
41
0.040
Why?
Thailand
2
2008
91
0.040
Why?
Specialization
1
2015
54
0.040
Why?
Fatal Outcome
1
2015
90
0.040
Why?
Pedigree
1
2015
157
0.040
Why?
Prospective Studies
2
1996
1691
0.040
Why?
Hematopoietic Stem Cell Transplantation
1
2015
154
0.040
Why?
Killer Cells, Natural
1
2015
192
0.040
Why?
Tissue Array Analysis
1
2013
16
0.040
Why?
Survival Analysis
1
2014
382
0.040
Why?
Consanguinity
1
2012
6
0.030
Why?
Gene Rearrangement, T-Lymphocyte
1
2012
6
0.030
Why?
Government Programs
1
2012
8
0.030
Why?
Lymphocyte Count
1
2012
70
0.030
Why?
Lentivirus
1
2012
30
0.030
Why?
DNA Copy Number Variations
1
2012
30
0.030
Why?
Adenylate Kinase
1
2012
14
0.030
Why?
Cell Line, Transformed
1
2012
83
0.030
Why?
Blood
1
1992
27
0.030
Why?
Thymus Gland
1
2013
220
0.030
Why?
Hearing Loss
1
2012
19
0.030
Why?
Professional Role
1
2012
30
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2013
270
0.030
Why?
Heart Defects, Congenital
1
2012
55
0.030
Why?
Genes, Reporter
1
2012
186
0.030
Why?
Specimen Handling
1
1992
34
0.030
Why?
Public Health
1
2012
104
0.030
Why?
Prognosis
1
2014
946
0.030
Why?
Herpesvirus 4, Human
1
2012
130
0.030
Why?
Lymphocytes
1
1992
180
0.030
Why?
Mass Spectrometry
2
2002
207
0.030
Why?
New York
1
2010
66
0.030
Why?
Health Personnel
1
2012
150
0.030
Why?
Antigens, CD45
1
2010
52
0.030
Why?
Infant, Low Birth Weight
1
2010
34
0.030
Why?
Antigens, CD3
1
2010
60
0.030
Why?
Patient Advocacy
1
2010
22
0.030
Why?
Leukocytes
1
2010
106
0.030
Why?
Leishmania
1
1989
9
0.030
Why?
RNA Viruses
1
1989
7
0.030
Why?
Gram-Negative Aerobic Rods and Cocci
1
2009
1
0.030
Why?
Gram-Positive Cocci
1
2009
2
0.030
Why?
Infant Care
1
2008
5
0.030
Why?
Genetic Vectors
1
2012
484
0.030
Why?
Infant Formula
1
2008
6
0.030
Why?
Carnitine
1
2008
14
0.030
Why?
RNA, Messenger
1
2013
1261
0.020
Why?
Breast Feeding
1
2008
41
0.020
Why?
Case-Control Studies
1
2009
669
0.020
Why?
Histidine
1
2006
27
0.020
Why?
Age of Onset
1
2006
130
0.020
Why?
Pseudomonas aeruginosa
1
2006
60
0.020
Why?
Arginine
1
2006
80
0.020
Why?
Risk Assessment
1
2010
1098
0.020
Why?
Pilocarpine
1
2005
2
0.020
Why?
Muscarinic Agonists
1
2005
7
0.020
Why?
Mutation, Missense
1
2006
120
0.020
Why?
Early Diagnosis
1
2005
43
0.020
Why?
Prenatal Diagnosis
1
2004
22
0.020
Why?
Linear Models
1
2005
339
0.020
Why?
Pregnancy
2
2000
1213
0.020
Why?
Infection Control
1
2004
37
0.020
Why?
Patient Selection
1
2005
306
0.020
Why?
Health Education
1
2004
175
0.020
Why?
RNA Stability
1
2003
70
0.020
Why?
Viral Load
1
2003
178
0.020
Why?
Age Factors
1
2005
1100
0.020
Why?
Sweating
1
2001
13
0.020
Why?
Electrolytes
1
2001
23
0.020
Why?
Mice
1
2013
7376
0.020
Why?
Antiviral Agents
1
2003
159
0.020
Why?
Heterozygote
1
2001
119
0.020
Why?
Labor, Obstetric
1
2000
24
0.010
Why?
Drug Administration Schedule
1
2000
226
0.010
Why?
Animals
2
2013
14659
0.010
Why?
Pregnancy Outcome
1
2000
111
0.010
Why?
Double-Blind Method
1
2000
497
0.010
Why?
Seroepidemiologic Studies
1
1997
18
0.010
Why?
Spain
1
1997
24
0.010
Why?
HIV-2
1
1997
23
0.010
Why?
Puerto Rico
1
1996
103
0.010
Why?
Adult
2
2000
9806
0.010
Why?
Prevalence
1
1997
808
0.010
Why?
HIV Antigens
1
1990
22
0.010
Why?
Virus Cultivation
1
1990
18
0.010
Why?
Acquired Immunodeficiency Syndrome
1
1990
124
0.010
Why?
Nucleic Acid Hybridization
1
1989
96
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
1990
403
0.010
Why?
DNA-Directed RNA Polymerases
1
1989
44
0.010
Why?
Microscopy, Electron
1
1989
226
0.010
Why?
Species Specificity
1
1989
297
0.010
Why?
Comeau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_